Literature DB >> 24213674

Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity.

Jihye Han1, Seung Bae Rho, Jae Yeon Lee, Joonbeom Bae, Se Ho Park, Suk Jun Lee, Sang Yeol Lee, Curie Ahn, Jae Young Kim, Taehoon Chun.   

Abstract

To avoid host immune surveillance, human cytomegalovirus (HCMV) encoded endoplasmic reticulum (ER)-membrane glycoprotein US2, which interferes with antigen presenting mechanism of Major histocompatibility complex (MHC) class Ia and class II molecules. However, not many attempts have been made to study the effect of HCMV US2 on the expression of MHC class Ib molecules. In this study, we examined the effect of HCMV US2 on the expression and function of human CD1d (hCD1d), which presents glycolipid antigens to invariant NKT (iNKT) cells. Our results clearly showed that the physiological interaction between ER lumenal domain of HCMV US2 and α3 domain of hCD1d was observed within ER. Compared with mature form of hCD1d, immature form of hCD1d is more susceptible to ubiquitin-dependent proteasomal degradation mediated by HCMV US2. Moreover, the ectopic expression of HCMV US2 leads to the down-modulation of iNKT cell activity without significant change of hCD1d expression. These results will advance our understanding of the function of HCMV US2 in immune evasive mechanisms against anti-viral immunity of iNKT cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24213674      PMCID: PMC3887943          DOI: 10.1007/s10059-013-0221-8

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  43 in total

Review 1.  Can viruses help us to understand and classify the MHC class I molecules at the maternal-fetal interface?

Authors:  M H Furman; H L Ploegh; D J Schust
Journal:  Hum Immunol       Date:  2000-11       Impact factor: 2.850

2.  US2, a human cytomegalovirus-encoded type I membrane protein, contains a non-cleavable amino-terminal signal peptide.

Authors:  Benjamin E Gewurz; Hidde L Ploegh; Domenico Tortorella
Journal:  J Biol Chem       Date:  2002-01-14       Impact factor: 5.157

3.  CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain.

Authors:  J Jayawardena-Wolf; K Benlagha; Y H Chiu; R Mehr; A Bendelac
Journal:  Immunity       Date:  2001-12       Impact factor: 31.745

Review 4.  Viral interference with antigen presentation to CD8+ T cells: lessons from cytomegalovirus.

Authors:  Amelia K Pinto; Ann B Hill
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

Review 5.  MHC class Ib molecules bridge innate and acquired immunity.

Authors:  John R Rodgers; Richard G Cook
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

6.  alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria.

Authors:  G Gonzalez-Aseguinolaza; C de Oliveira; M Tomaska; S Hong; O Bruna-Romero; T Nakayama; M Taniguchi; A Bendelac; L Van Kaer; Y Koezuka; M Tsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

7.  Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2.

Authors:  B E Gewurz; R Gaudet; D Tortorella; E W Wang; H L Ploegh; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

8.  CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes.

Authors:  B Wang; Y B Geng; C R Wang
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

9.  Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells.

Authors:  Stephanie K Dougan; Azucena Salas; Paul Rava; Amma Agyemang; Arthur Kaser; Jamin Morrison; Archana Khurana; Mitchell Kronenberg; Caroline Johnson; Mark Exley; M Mahmood Hussain; Richard S Blumberg
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

10.  Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

Authors:  K Kakimi; L G Guidotti; Y Koezuka; F V Chisari
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  7 in total

1.  Herpes Simplex Virus 1 US3 Phosphorylates Cellular KIF3A To Downregulate CD1d Expression.

Authors:  Ran Xiong; Ping Rao; Seil Kim; Michelle Li; Xiangshu Wen; Weiming Yuan
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

2.  Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.

Authors:  Raphaëlle Riou; Céline Bressollette-Bodin; David Boutoille; Katia Gagne; Audrey Rodallec; Maeva Lefebvre; François Raffi; David Senitzer; Berthe-Marie Imbert-Marcille; Christelle Retière
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

Review 3.  CD1d Expression and Invariant NKT Cell Responses in Herpesvirus Infections.

Authors:  Brian K Chung; John J Priatel; Rusung Tan
Journal:  Front Immunol       Date:  2015-06-25       Impact factor: 7.561

Review 4.  Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?

Authors:  Anne Halenius; Carolin Gerke; Hartmut Hengel
Journal:  Cell Mol Immunol       Date:  2014-11-24       Impact factor: 11.530

Review 5.  Human cytomegalovirus and autoimmune disease.

Authors:  Anne Halenius; Hartmut Hengel
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

Review 6.  CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil".

Authors:  Günther Schönrich; Martin J Raftery
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

7.  Contribution of NKT cells to the immune response and pathogenesis triggered by respiratory viruses.

Authors:  Emma Rey-Jurado; Karen Bohmwald; Nicolás M S Gálvez; Daniela Becerra; Steven A Porcelli; Leandro J Carreño; Alexis M Kalergis
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.